Patents by Inventor Axel Tardt

Axel Tardt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITION CONTAINING A TRYPTOPHAN DERIVATIVE
    Publication number: 20180118682
    Abstract: Pharmaceutical compositions containing a compound of formula (I) wherein the radicals denote e.g.: R1 is hydrogen or C1-C8-alkyl; R2 is hydrogen or C1-C8-alkyl; R3 is hydrogen or C1-C8-alkyl; R4 is OH; R5 is hydrogen, and a pharmaceutically acceptable cyclodextrin derivative can be used for the preparation of ophthalmic formulations.
    Type: Application
    Filed: December 20, 2017
    Publication date: May 3, 2018
    Applicant: Ramot at Tel-Aviv University Ltd.
    Inventors: Bernard HAUPTMEIER, Kevin KIEHM, Patrick PLITT, Axel TARDT, Alda SZLAK-FREIER, Diana STREHL
  • PHARMACEUTICAL COMPOSITION CONTAINING A TRYPTOPHAN DERIVATIVE
    Publication number: 20130197053
    Abstract: Pharmaceutical compositions containing a compound of formula (I) wherein the radicals denote e.g.: R1 is hydrogen or C1-C8-alkyl; R2 is hydrogen or C1-C8-alkyl; R3 is hydrogen or C1-C8-alkyl; R4 is OH; R5 is hydrogen, and a pharmaceutically acceptable cyclodextrin derivative can be used for the preparation of ophthalmic formulations.
    Type: Application
    Filed: July 6, 2011
    Publication date: August 1, 2013
    Applicant: MERZ PHARMA GMBH & CO. KGAA
    Inventors: Bernard Hauptmeier, Kevin Kiehm, Patrick Plitt, Axel Tardt, Alda Szlak-Freier, Diana Strehl